{"id":"NCT01942785","sponsor":"H. Lundbeck A/S","briefTitle":"Study of Brexpiprazole as Adjunctive Treatment of Irritability in Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Therapy","officialTitle":"Interventional, Open-label, Flexible-dose, Exploratory Study of Brexpiprazole as Adjunctive Treatment of Irritability in Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Therapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-10","primaryCompletion":"2014-07","completion":null,"firstPosted":"2013-09-16","resultsPosted":"2016-03-15","lastUpdate":"2016-03-15"},"enrollment":55,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Major Depressive Disorder","Irritability"],"interventions":[{"type":"DRUG","name":"Brexpiprazole","otherNames":[]}],"arms":[{"label":"Brexpiprazole","type":"EXPERIMENTAL"}],"summary":"To explore the anti-impulsive and anti-aggressive properties of brexpiprazole in a naturalistic setting of depressed patients with irritability.","primaryOutcome":{"measure":"Change From Baseline to Week 6 in SIS Total Score","timeFrame":"Baseline and Week 6","effectByArm":[{"arm":"Brexpiprazole","deltaMin":-21.13,"sd":2.55}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":9},"locations":{"siteCount":15,"countries":["United States"]},"refs":{"pmids":["27379823"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":54},"commonTop":["Akathisia","Headache","Dry mouth","Fatigue","Increased appetite"]}}